Congenital heart defects after maternal fever

Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-base...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2014-04, Vol.210 (4), p.359.e1-359.e11
Hauptverfasser: Botto, Lorenzo D., MD, Panichello, Janice D., PhD, Browne, Marilyn L., PhD, Krikov, Sergey, MS, Feldkamp, Marcia L., PhD, Lammer, Edward, MD, Shaw, Gary M., DrPH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 359.e11
container_issue 4
container_start_page 359.e1
container_title American journal of obstetrics and gynecology
container_volume 210
creator Botto, Lorenzo D., MD
Panichello, Janice D., PhD
Browne, Marilyn L., PhD
Krikov, Sergey, MS
Feldkamp, Marcia L., PhD
Lammer, Edward, MD
Shaw, Gary M., DrPH
description Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, >3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.
doi_str_mv 10.1016/j.ajog.2013.10.880
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1511820728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S000293781301990X</els_id><sourcerecordid>1511820728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</originalsourceid><addsrcrecordid>eNo9kFtLxDAQhYMo7rr6B3yQPvrSOkl6SV4EWbzBgg8q-BZm2-na2osm7cL-e1N2FYYMmZwznHyMXXKIOPD0po6w7jeRAC79IFIKjticg87CVKXqmM0BQIRaZmrGzpyrp6vQ4pTNRMyVL5izcNl3G-qqAZvgk9AOQUEl5YMLsBzIBi36s_OPJW3JnrOTEhtHF4e-YO8P92_Lp3D18vi8vFuFuUzUEGY-SpEIpBRS1JlUOgbAOCedUCxjKeJ1hqBULjKtKcUCS5miUqVEVRRrKRfser_32_Y_I7nBtJXLqWmwo350hiecKwGZUF4q9tLc9s5ZKs23rVq0O8PBTJhMbSZMZsI0zXw2b7o67B_XLRX_lj8uXnC7F5D_5bYia_Km6qocmy_akav7cYLigxgnDJjXCe0EmkvgWsOH_AXMR3e9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1511820728</pqid></control><display><type>article</type><title>Congenital heart defects after maternal fever</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH</creator><creatorcontrib>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH ; National Birth Defects Prevention Study</creatorcontrib><description>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, &gt;3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2013.10.880</identifier><identifier>PMID: 24184180</identifier><language>eng</language><publisher>United States</publisher><subject>Antipyretics - therapeutic use ; Case-Control Studies ; Female ; Fever - drug therapy ; Fever - epidemiology ; Heart Defects, Congenital - epidemiology ; Humans ; Infant, Newborn ; Obstetrics and Gynecology ; Pelvic Inflammatory Disease - epidemiology ; Pregnancy ; Pregnancy Complications - drug therapy ; Pregnancy Complications - epidemiology ; Respiratory Tract Infections - epidemiology ; Risk Assessment ; United States - epidemiology ; Urinary Tract Infections - epidemiology ; Vitamins - therapeutic use</subject><ispartof>American journal of obstetrics and gynecology, 2014-04, Vol.210 (4), p.359.e1-359.e11</ispartof><rights>Mosby, Inc.</rights><rights>Copyright © 2014 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</citedby><cites>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24184180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Botto, Lorenzo D., MD</creatorcontrib><creatorcontrib>Panichello, Janice D., PhD</creatorcontrib><creatorcontrib>Browne, Marilyn L., PhD</creatorcontrib><creatorcontrib>Krikov, Sergey, MS</creatorcontrib><creatorcontrib>Feldkamp, Marcia L., PhD</creatorcontrib><creatorcontrib>Lammer, Edward, MD</creatorcontrib><creatorcontrib>Shaw, Gary M., DrPH</creatorcontrib><creatorcontrib>National Birth Defects Prevention Study</creatorcontrib><title>Congenital heart defects after maternal fever</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, &gt;3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</description><subject>Antipyretics - therapeutic use</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Fever - drug therapy</subject><subject>Fever - epidemiology</subject><subject>Heart Defects, Congenital - epidemiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Obstetrics and Gynecology</subject><subject>Pelvic Inflammatory Disease - epidemiology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Pregnancy Complications - epidemiology</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Risk Assessment</subject><subject>United States - epidemiology</subject><subject>Urinary Tract Infections - epidemiology</subject><subject>Vitamins - therapeutic use</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kFtLxDAQhYMo7rr6B3yQPvrSOkl6SV4EWbzBgg8q-BZm2-na2osm7cL-e1N2FYYMmZwznHyMXXKIOPD0po6w7jeRAC79IFIKjticg87CVKXqmM0BQIRaZmrGzpyrp6vQ4pTNRMyVL5izcNl3G-qqAZvgk9AOQUEl5YMLsBzIBi36s_OPJW3JnrOTEhtHF4e-YO8P92_Lp3D18vi8vFuFuUzUEGY-SpEIpBRS1JlUOgbAOCedUCxjKeJ1hqBULjKtKcUCS5miUqVEVRRrKRfser_32_Y_I7nBtJXLqWmwo350hiecKwGZUF4q9tLc9s5ZKs23rVq0O8PBTJhMbSZMZsI0zXw2b7o67B_XLRX_lj8uXnC7F5D_5bYia_Km6qocmy_akav7cYLigxgnDJjXCe0EmkvgWsOH_AXMR3e9</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Botto, Lorenzo D., MD</creator><creator>Panichello, Janice D., PhD</creator><creator>Browne, Marilyn L., PhD</creator><creator>Krikov, Sergey, MS</creator><creator>Feldkamp, Marcia L., PhD</creator><creator>Lammer, Edward, MD</creator><creator>Shaw, Gary M., DrPH</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Congenital heart defects after maternal fever</title><author>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antipyretics - therapeutic use</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Fever - drug therapy</topic><topic>Fever - epidemiology</topic><topic>Heart Defects, Congenital - epidemiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Obstetrics and Gynecology</topic><topic>Pelvic Inflammatory Disease - epidemiology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Pregnancy Complications - epidemiology</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Risk Assessment</topic><topic>United States - epidemiology</topic><topic>Urinary Tract Infections - epidemiology</topic><topic>Vitamins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Botto, Lorenzo D., MD</creatorcontrib><creatorcontrib>Panichello, Janice D., PhD</creatorcontrib><creatorcontrib>Browne, Marilyn L., PhD</creatorcontrib><creatorcontrib>Krikov, Sergey, MS</creatorcontrib><creatorcontrib>Feldkamp, Marcia L., PhD</creatorcontrib><creatorcontrib>Lammer, Edward, MD</creatorcontrib><creatorcontrib>Shaw, Gary M., DrPH</creatorcontrib><creatorcontrib>National Birth Defects Prevention Study</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Botto, Lorenzo D., MD</au><au>Panichello, Janice D., PhD</au><au>Browne, Marilyn L., PhD</au><au>Krikov, Sergey, MS</au><au>Feldkamp, Marcia L., PhD</au><au>Lammer, Edward, MD</au><au>Shaw, Gary M., DrPH</au><aucorp>National Birth Defects Prevention Study</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital heart defects after maternal fever</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>210</volume><issue>4</issue><spage>359.e1</spage><epage>359.e11</epage><pages>359.e1-359.e11</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, &gt;3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</abstract><cop>United States</cop><pmid>24184180</pmid><doi>10.1016/j.ajog.2013.10.880</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2014-04, Vol.210 (4), p.359.e1-359.e11
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_1511820728
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antipyretics - therapeutic use
Case-Control Studies
Female
Fever - drug therapy
Fever - epidemiology
Heart Defects, Congenital - epidemiology
Humans
Infant, Newborn
Obstetrics and Gynecology
Pelvic Inflammatory Disease - epidemiology
Pregnancy
Pregnancy Complications - drug therapy
Pregnancy Complications - epidemiology
Respiratory Tract Infections - epidemiology
Risk Assessment
United States - epidemiology
Urinary Tract Infections - epidemiology
Vitamins - therapeutic use
title Congenital heart defects after maternal fever
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A21%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20heart%20defects%20after%20maternal%20fever&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Botto,%20Lorenzo%20D.,%20MD&rft.aucorp=National%20Birth%20Defects%20Prevention%20Study&rft.date=2014-04-01&rft.volume=210&rft.issue=4&rft.spage=359.e1&rft.epage=359.e11&rft.pages=359.e1-359.e11&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2013.10.880&rft_dat=%3Cproquest_cross%3E1511820728%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1511820728&rft_id=info:pmid/24184180&rft_els_id=1_s2_0_S000293781301990X&rfr_iscdi=true